Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Alibaba
BABA
|
+$1.51B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
| 3 |
Amazon
AMZN
|
+$752M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$719M |
| 5 |
Microsoft
MSFT
|
+$625M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.94B |
| 2 |
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
|
+$703M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$697M |
| 4 |
Middleby
MIDD
|
+$596M |
| 5 |
TSMC
TSM
|
+$574M |
Sector Composition
| 1 | Technology | 17.23% |
| 2 | Consumer Discretionary | 11.16% |
| 3 | Financials | 10.25% |
| 4 | Healthcare | 9.65% |
| 5 | Communication Services | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELL
1626
DELISTED
PhenomeX Inc. Common Stock
CELL
| $21.4M | 0.01% |
426,039
+248,822
| +140% | +$12.5M |
|
1627
CarGurus
CARG
$3.58B
| $21.4M | 0.01% |
897,455
-79,286
| -8% | -$1.89M |
|
1628
Vanguard Russell 1000 Growth ETF
VONG
$31.9B
| $21.4M | 0.01% |
341,964
+165,660
| +94% | +$10.4M |
|
1629
WD-40
WDFC
$2.86B
| $21.2M | 0.01% |
69,399
+15,204
| +28% | +$4.66M |
|
1630
SPDR Dow Jones REIT ETF
RWR
$1.88B
| $21.2M | 0.01% |
223,999
-17,425
| -7% | -$1.65M |
|
|
DMYI.U
1631
DELISTED
dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
DMYI.U
| $21.2M | 0.01% |
1,900,147
+847,267
| +80% | +$9.46M |
|
1632
Ternium
TX
$6.8B
| $21.2M | 0.01% |
545,917
+449,558
| +467% | +$17.5M |
|
1633
Nomura Holdings
NMR
$22B
| $21.2M | 0.01% |
3,953,580
+151,718
| +4% | +$813K |
|
1634
iShares US Basic Materials ETF
IYM
$569M
| $21.1M | 0.01% |
168,318
-50,943
| -23% | -$6.4M |
|
|
IPOF
1635
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $21.1M | 0.01% |
1,967,291
+540,879
| +38% | +$5.79M |
|
|
TWNK
1636
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $21.1M | 0.01% |
1,469,112
-867,568
| -37% | -$12.4M |
|
|
IMGN
1637
DELISTED
Immunogen Inc
IMGN
| $21M | 0.01% |
2,595,999
-24,646
| -0.9% | -$200K |
|
1638
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| $21M | 0.01% |
229,692
+1,308
| +0.6% | +$120K |
|
1639
VanEck Biotech ETF
BBH
$349M
| $21M | 0.01% |
119,442
+50,000
| +72% | +$8.77M |
|
1640
Simmons First National
SFNC
$2.96B
| $20.9M | 0.01% |
704,102
-214,807
| -23% | -$6.37M |
|
1641
Synovus
SNV
$7.18B
| $20.9M | 0.01% |
456,573
+44,493
| +11% | +$2.04M |
|
|
GMIIU
1642
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
| $20.9M | 0.01% |
+2,065,895
| New | +$20.9M |
|
|
PBFX
1643
DELISTED
PBF LOGISTICS LP
PBFX
| $20.8M | 0.01% |
1,415,914
-114,620
| -7% | -$1.69M |
|
1644
Element Solutions
ESI
$6.36B
| $20.8M | 0.01% |
1,139,231
+498,270
| +78% | +$9.11M |
|
1645
Vistra
VST
$71.1B
| $20.8M | 0.01% |
1,178,515
-197,203
| -14% | -$3.49M |
|
1646
Dycom Industries
DY
$7.47B
| $20.8M | 0.01% |
224,203
+23,297
| +12% | +$2.16M |
|
|
BHVN
1647
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.7M | 0.01% |
303,516
-215,362
| -42% | -$14.7M |
|
|
WWE
1648
DELISTED
World Wrestling Entertainment
WWE
| $20.7M | 0.01% |
381,988
+39,582
| +12% | +$2.15M |
|
|
AAT
1649
American Assets Trust
AAT
$1.27B
| $20.7M | 0.01% |
637,710
+29,850
| +5% | +$968K |
|
1650
Travere Therapeutics
TVTX
$2.09B
| $20.7M | 0.01% |
827,434
+113,468
| +16% | +$2.83M |
|